Analysts Viewpoint
EVP & Chief Financial Officer Schorno Dean L sold 2,036 shares of Rigel Pharmaceuticals [RIGL]
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Rigel Pharmaceuticals Inc. (RIGL), a biotechnology company specializing to manufacture and commercialize novel molecule drugs, soared 12.14% at $3.46 in